EP Wealth Advisors LLC raised its position in shares of Xylem Inc. (NYSE:XYL - Free Report) by 8.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 166,100 shares of the industrial products company's stock after purchasing an additional 12,557 shares during the quarter. EP Wealth Advisors LLC owned 0.07% of Xylem worth $19,842,000 at the end of the most recent quarter.
Other large investors also recently added to or reduced their stakes in the company. Center for Financial Planning Inc. grew its position in Xylem by 52.0% during the first quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock valued at $32,000 after purchasing an additional 91 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. grew its position in Xylem by 3.0% during the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 3,450 shares of the industrial products company's stock valued at $412,000 after purchasing an additional 99 shares in the last quarter. Valley National Advisers Inc. grew its position in Xylem by 84.9% during the first quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock valued at $26,000 after purchasing an additional 101 shares in the last quarter. Ascent Wealth Partners LLC grew its position in Xylem by 0.7% during the first quarter. Ascent Wealth Partners LLC now owns 14,229 shares of the industrial products company's stock valued at $1,700,000 after purchasing an additional 101 shares in the last quarter. Finally, Blue Trust Inc. grew its position in Xylem by 25.1% during the first quarter. Blue Trust Inc. now owns 539 shares of the industrial products company's stock valued at $64,000 after purchasing an additional 108 shares in the last quarter. 87.96% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
XYL has been the topic of a number of research analyst reports. Raymond James Financial raised shares of Xylem to a "hold" rating in a research report on Thursday, May 15th. TD Cowen boosted their price objective on shares of Xylem from $125.00 to $130.00 and gave the company a "hold" rating in a research report on Tuesday, August 26th. Stifel Nicolaus lifted their target price on shares of Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a research note on Friday, August 1st. Citigroup reiterated a "buy" rating and issued a $152.00 target price (up from $137.00) on shares of Xylem in a research note on Monday, July 14th. Finally, UBS Group lifted their target price on shares of Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a research note on Tuesday, August 5th. Six investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $152.29.
Read Our Latest Report on XYL
Insider Buying and Selling
In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company's stock in a transaction on Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the completion of the transaction, the chief accounting officer directly owned 2,957 shares in the company, valued at $413,861.72. This represents a 25.27% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.27% of the stock is currently owned by insiders.
Xylem Stock Performance
Shares of Xylem stock traded down $1.42 on Friday, reaching $140.52. The stock had a trading volume of 1,170,902 shares, compared to its average volume of 998,635. The business's 50-day moving average price is $137.36 and its two-hundred day moving average price is $127.24. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.90. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $145.33. The stock has a market cap of $34.20 billion, a P/E ratio of 36.50, a price-to-earnings-growth ratio of 2.45 and a beta of 1.09.
Xylem (NYSE:XYL - Get Free Report) last released its earnings results on Thursday, July 31st. The industrial products company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.15 by $0.11. The firm had revenue of $2.30 billion during the quarter, compared to analysts' expectations of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The business's quarterly revenue was up 6.1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, sell-side analysts forecast that Xylem Inc. will post 4.65 EPS for the current year.
Xylem Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Thursday, August 28th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.1%. The ex-dividend date is Thursday, August 28th. Xylem's dividend payout ratio is presently 41.56%.
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Stories

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.